Highlights Eckert & Ziegler SE London S.E.

Equities

0NZY

DE0005659700

Market Closed - London S.E. Other stock markets 11:30:00 2024-07-05 EDT			After market 12:29:36
46.29 ^EUR	+0.70%		45.97	-0.69%

07-04	ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	ZD
06-25	German Stocks Fall Tuesday	DJ

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ex-dividend day for final dividend	06-26	FA
German Stocks Fall Tuesday	06-25	DJ
Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic	06-25	MT
Announcement drives Eckert & Ziegler - shares above 21-day line	06-25	DP
Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Eckert & Ziegler increases profit at the start of the year - targets confirmed	04-22	DP
Eckert & Ziegler SE Reaffirms Earnings Guidance for the Year 2024	04-22	CI
RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals	04-04	CI
Eckert & Ziegler SE Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
Eckert & Ziegler recovers - Dividend disappointed - 'Balance sheet strong'	03-20	DP
Eckert & Ziegler cuts dividend in favor of investments	03-20	DP
Eckert & Ziegler plans further growth - dividend decreases significantly	03-19	DP
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177	01-31	CI
Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Eckert & Ziegler and Ablaze Pharmaceuticals Sign Comprehensive Supply Agreement for Non-Carrier Added Lutetium-177	23-10-23	CI
Eckert & Ziegler wants to spin off subsidiary Pentixapharm - share price jumps	23-10-20	DP
Eckert & Ziegler prepares spin-off of subsidiary Pentixapharm	23-10-20	DP
Eckert & Ziegler Strahlen- Und Medizintechnik Ag Confirms Earnings Guidance for the Year 2023	23-10-17	CI
US drug developer secures cancer compound from Eckert & Ziegler	23-10-10	DP
Eckert & Ziegler and PharmaLogic Holdings Corp. Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225	23-10-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Eckert & Ziegler SE London S.E.

Equities

0NZY

DE0005659700

Highlights

Filters